SCHEMBL19969355

SCHEMBL19969355

CCOC(=O)CCCCCCNC1CCc2ccccc21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NAMPT P43490 1/20 0.54
▸ HTR2C P28335 1/20 0.50
▸ SLC6A3 Q01959 1/20 0.50
▸ MAOA P21397 3/20 0.49
▸ MAOB P27338 3/20 0.49
▸ ALDH1A1 P00352 2/20 0.48
▸ BCHE P06276 1/20 0.46
▸ ADRA2B P18089 1/20 0.46
▸ ADRA2C P18825 1/20 0.46
▸ ACHE P22303 1/20 0.46
▸ ADRA1A P35348 1/20 0.46
▸ HTR6 P50406 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ EPHX2 P34913 3/20 0.43
▸ PDPK1 O15530 1/20 0.43
▸ HTT P42858 1/20 0.42
▸ CYP4F2 P78329 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7419274 0.90 ALDH1A1 (0.52) NAMPTMAOAMAOBALDH1A1BCHE
SCHEMBL11010091 0.83 MAOA (0.52) MAOAMAOBALDH1A1BCHEADRA2B
Hydrochloric Acid SCHEMBL9725935 0.82 MAOA (0.51) MAOAMAOBALDH1A1BCHEADRA2B
SCHEMBL6923878 0.78 MAOA (0.59) MAOAMAOBBCHEADRA2BADRA2C
SCHEMBL172566 0.77 MAOA (0.60) MAOAMAOBBCHEADRA2BADRA2C
SCHEMBL11005532 0.76 ALDH1A1 (0.58) ALDH1A1KDM4EMEN1KMT2AHPGD
Hydrochloric Acid SCHEMBL11012783 0.75 ALDH1A1 (0.57) ALDH1A1KDM4EMEN1KMT2AHPGD
SCHEMBL12269128 0.74 HTR2C (0.55) HTR2CSLC6A3MAOAMAOBALDH1A1
SCHEMBL917662 0.74 MAOA (0.60) HTR2CSLC6A3MAOAMAOBALDH1A1
SCHEMBL918896 0.74 MAOA (0.60) HTR2CSLC6A3MAOAMAOBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11634434-B2 Bifunctional alpha-synuclein binding agents and uses thereof UNIVERSITY OF SASKATCHEWAN (CA) 2023-04-25 — — US disclosed
US-20200062782-A1 BIFUNCTIONAL ALPHA-SYNUCLEIN BINDING AGENTS AND USES THEREOF UNIVERSITY OF SASKATCHEWAN (CA) 2020-02-27 — — US disclosed
WO-2018045464-A1 BIFUNCTIONAL ALPHA-SYNUCLEIN BINDING AGENTS AND USES THEREOF UNIVERSITY OF SASKATCHEWAN (CA) 2018-03-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200062782-A1 BIFUNCTIONAL ALPHA-SYNUCLEIN BINDING AGENTS AND USES THEREOF SNCA, PARK7, SYNJ2 NAMPT 3421/4885HTR2C 2631/4885SLC6A3 229/4885
US-11634434-B2 Bifunctional alpha-synuclein binding agents and uses thereof SNCA, PARK7, SYNJ2 NAMPT 3421/4885HTR2C 2631/4885SLC6A3 229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback